// App-Quantinova.ai

TCT-74 : Using a Protocolized Approach and a Dedicated Shock Team Leads to Significant Reductions in 30-day Mortality in Acute Coronary Syndrome Patients With Cardiogenic Shock

Researchers

Presenter

  • Maria Monteagudo Vela

Principal Investigators

  • Alex Rosengerb

  • Francesca Fiorelli

  • Alexander Tindale

  • Vasileios Panoulas

Medical Centers

  • Royal Brompton and Harefield Hospitals, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom

  • Hematology, Hospital Universitario de La Princesa, MADRID, Spain

Locations

  • United Kingdom

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Cardiogenic shock

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved